Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Huachong Yu
Observed names:
H. Yu,
H.H.M. Yu,
Huihao Yu
Institutions:
Moffitt Cancer Center,
First Affiliated Hospital of Bengbu Medical College
Observed institutions:
Hiroshima University,
Fudan University,
Moffitt Cancer Center,
Fudan University Shanghai Cancer Center,
First Affiliated Hospital of Bengbu Medical College
ORCID:
0009-0000-3429-3495
Observed ORCID:
0009-0000-3429-3495
OpenAlex ID:
A5034020254
Clinical outcomes of melanoma brain metastases treated with stereotactic radiation and anti-PD-1 therapy
2015
·
K.A. Ahmed
, D.G. Stallworth
, et al.
·
Annals of Oncology
·
247
PDF
EarlGAN: An enhanced actor–critic reinforcement learning agent-driven GAN for de novo drug design
2023
·
Huidong Tang
, Chen Li
, et al.
·
Pattern Recognition Letters
·
22
Clinical Outcomes of Non-Small Cell Lung Cancer Brain Metastases Treated With Stereotactic Radiosurgery and Immune Checkpoint Inhibitors, EGFR Tyrosine Kinase Inhibitors, Chemotherapy and Immune Checkpoint Inhibitors, or Chemotherapy Alone
2021
·
A.E. Dohm
, J. Tang
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
6
Evaluation of the Neutrophil-Based Inflammatory Indexes SIRI and NHR in Patients with Extensive-Stage Small Cell Lung Cancer Receiving First-Line Immune Checkpoint Inhibitors Plus Chemotherapy.
2025
·
Yu Shao
, Xinyi Han
, et al.
·
PubMed
·
5
MacGAN: A Moment-Actor-Critic Reinforcement Learning-Based Generative Adversarial Network for Molecular Generation
2024
·
Huidong Tang
, Chen Li
, et al.
·
Lecture notes in computer science
·
5
Upfront Treatment With Osimertinib vs. Osimertinib and Radiotherapy for Patients With EGFR-Positive Non-Small Cell Lung Cancer Brain Metastases
2022
·
A.E. Dohm
, J. Tang
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
2
Comparison of Single MRI vs. Multiparametric MRI in GBM Image Data
2021
·
Y. Zhang
, D.T. Chen
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
2
PDF
Dosimetric Feasibility of HA-WBRT With an MRI-Guided Linear Accelerator
2021
·
J. Graham
, G. Redler
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
2
PDF
Multi-Institutional Report of Trastuzumab-Deruxtecan and Stereotactic Radiosurgery for HER2+ Breast Cancer Brain Metastases
2024
·
V. Khatri
, M. Mestres-Villanueva
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
1
Upfront Osimertinib Alone vs. Osimertinib and Radiotherapy for the Treatment of EGFR-Positive NSCLC Brain Metastases: A Multi-Institutional Series
2023
·
A.E. Dohm
, R. Upadhyay
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
1
PDF
Clinical Implementation and Utility of Triggered kV Imaging During Spine Stereotactic Body Radiotherapy for Intrafraction Motion Management
2021
·
J. Koo
, L. Nardella
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
·
1
Insights and Impact of a Dedicated Inpatient Radiation Oncology Service
2025
·
E. Keit
, A. Ruane
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
PDF
Inpatient Radiotherapy: Insights for Hemostasis Consults
2025
·
S.A. Polce
, E. Keit
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
PDF
Real-World Use of Nivolumab plus Relatlimab in the Multi-Modal Management of Melanoma Brain Metastases
2025
·
V.M. Khatri
, M.T. Aboujaoude
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Presentation and Outcomes for Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Melanoma Presenting with Leptomeningeal Disease at the Time of Initial Central Nervous System Involvement
2024
·
R. Tang
, Y. Pina
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Clinical Outcomes Following Stereotactic Radiosurgery in Breast Cancer Brain Metastasis with or without Systemic Metastasis
2024
·
D. Zhao
, V. Khatri
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Palliative Whole Brain Radiotherapy: International State of Practice 2022
2023
·
E. Keit
, S.F. Lee
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
PDF
Stereotactic Radiosurgery and Anti-PD-1 + CTLA-4 Therapy, Anti-PD-1 Therapy, Anti-CTLA-4 Therapy, BRAF/MEK Inhibitors, BRAF Inhibitor, or Conventional Chemotherapy for the Management of Melanoma Brain Metastases
2022
·
A.E. Dohm
, H. Kalagotla
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Characterization of Immune Infiltrates Associated with Radiation Necrosis in the Setting of Brain Metastases Following Stereotactic Radiosurgery and Immunotherapy
2022
·
S.X. Jiang
, R.J. Macaulay
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Evaluation of Molecular Determinants Related to Outcomes in Recurrent High Grade Glioma Treated With Hypofractionated Stereotactic Radiotherapy (HFSRT) and Immune Checkpoint Blockade
2021
·
E. Guvenli
, D. Grass
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
PDF
Immune Cell Infiltrates of the Tumor Microenvironment and Radiosensitivity of Recurrent Glioblastomas and Their Association With Outcome
2021
·
A. Rishi
, H. Mohammadi
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Patterns of Failure in Patients With Recurrent High-Grade Glioma Treated With Hypofractionated Stereotactic Re-Irradiation, Pembrolizumab, and Bevacizumab
2021
·
R. Padmanabhan
, G.G. Zhang
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
PDF
Brain Metastases Outcomes In Patients With Melanoma, Non-Small Cell Lung Cancer, And Breast Cancer And Implications For Screening Brain MRIs
2020
·
T. Potluri
, M. Fahey
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
1801P Safety and efficacy of anlotinib combined with etoposide and platinum-based regimens in the first-line treatment of extensive-stage small cell lung cancer
2020
·
C. Liu
, J. Wang
, et al.
·
Annals of Oncology
PDF
A Comparison of Outcomes in Recurrent High Grade Gliomas Treated With Hypofractionated Stereotactic Radiation Therapy With or Without Programmed Cell Death Protein 1 (PD-1) Blockade
2017
·
G.D. Grass
, S. Sahebjam
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
Show more works
View as search
Works count:
27
Citation count:
294
H-index:
5
I10-index:
2
Year
Topic
Type